Victrex (LON:VCT) shares tumbled on Tuesday, sliding 7% by mid-morning following the announcement that James Routh, current CEO of AB Dynamics, will take the helm at the polymer specialist.
AB Dynamics, meanwhile, felt a gentler impact with shares dipping 1.8%.
Routh is set to succeed Jakob Sigurdsson, who is retiring after eight years in charge, though no official start date has been set. AB Dynamics confirmed the move but noted Routh faces a 12-month notice period, leaving their chair, Dick Elsy, to begin the hunt for a new leader.
Victrex described Routh’s background as well aligned with its business, highlighting his experience in manufacturing and engineering from previous roles at AB Dynamics, Diploma PLC, Chemring, and Cobham.
The share price slump came amid a trading update revealing that while volume growth remained strong in the quarter ending June 30, up 8% year-on-year to 1,057 tonnes, revenue slipped 3.4% to £71.5 million, pulled down by a weaker-than-expected performance in the Medical division. Over nine months, volume rose 13%, but revenue only nudged up 1.9%.
Victrex pointed to a tough spell in its Spine business, hit by industry destocking, volume-based pricing pressures in China, and competition from alternative materials in the US market. The average selling price also dropped 11% to £68 per kilogramme, influenced by a mix of product sales and pricing pressure in Medical and Sustainable Solutions.
Currency headwinds are expected to shave around £9 million off pretax profits, at the top end of prior guidance.
While Sigurdsson maintained the company targets a second-half underlying pretax profit above the £23.2 million recorded in the first half, he conceded that recent sales trends point to a second-half outcome broadly matching the first.
Victrex is due to publish its full financial year 2025 results on December 2.